What can the biotechnology industry do for neglected diseases (infectious diseases that, because they primarily afflict low-income countries, are not heavily researched in the public or private sector)? Biotechnology enthusiasts might answer “everything,” ignoring the dearth of research and development incentives for small biotechnology firms, much less the major challenges presented by the manufacture, distribution,… Continue reading The Biotechnology of Neglect
Tag: biotechnology
Cash Crash
Think you’re the only one stashing your financial statements in a filing cabinet without first opening them? How do you think biotechnology companies feel? Today’s New York Times ran a story by Andrew Pollack (“Broader Financial Turmoil Threatens Biotech’s Innovation and Cash”) describing the impact of the economic downturn on the biotechnology sector. Among the… Continue reading Cash Crash